Your European partner for integrated
Regulatory Pathways & Clinical Supply

Specialized in Advanced Therapies
Supporting Clinical Supply across all IMPs
About us
Scroll
1

Scientific Expertise

Cell Therapies • Gene Therapies • Tissue Engineering • Innovative Medicines

Scientific Expertise

Cell Therapies • Gene Therapies • Tissue Engineering • Innovative Medicines

2

Regulatory Expertise

EMA • AEMPS • CTA • IMPD • Scientific Advice • Hospital Exemption

Regulatory Expertise

EMA • AEMPS • CTA • IMPD • Scientific Advice • Hospital Exemption

3

Quality Expertise

GMP • QMS • Audits •Trainings • CAPA • Vendor Qualification

Quality Expertise

GMP • QMS • Audits •Trainings • CAPA • Vendor Qualification

4

Operational Expertise

Global Clinical Supply • QP Release • Import/Export • Biorepository services

Operational Expertise

Global Clinical Supply • QP Release • Import/Export • Biorepository services

Regulatory Pathways

"My deepest gratitud to Advanthera and Regulatory Pathways team for their unwavering support. What began as an immunological idea is now the first targeted secretome in Phase I-II human trials, approved by the EMA and the first of its kind. This achievement would not have been possible without your guidance and expertise."

CEO – Biotech developing Advanced Therapies

Regulatory Pathways

"Gradocell is not just a consultancy firm; it's your indispensable partner in the conception, development, and implementation of Advanced Therapy Medicinal Products Production Units. We seamlessly integrate into your team, providing unwavering support every step of the way."

Partner at a Hospital In Madrid – Advanced Therapies Unit

Precise Supply

"We manage the entire supply chain with meticulous care, ensuring the success of your clinical trial from planning to closure. With our comprehensive end-to-end approach, we provide unwavering support for your clinical trials."

Santiago de Vega
General Manager, Advanthera Precise Supply

Precise Supply